Format

Send to

Choose Destination
See comment in PubMed Commons below
MAbs. 2010 Jul-Aug;2(4):365-78. Epub 2010 Jul 1.

Mining human antibody repertoires.

Author information

1
Cytos Biotechnology, Schlieren, Switzerland.
2
2Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute.

Abstract

Human monoclonal antibodies (mAbs) have become drugs of choice for the management of an increasing number of human diseases.  Human antibody repertoires provide a rich source for human mAbs.  Here we review the characteristics of natural and non-natural human antibody repertoires and their mining with non-combinatorial and combinatorial strategies.  In particular, we discuss the selection of human mAbs from naïve, immune, transgenic, and synthetic human antibody repertoires using methods based on hybridoma technology, clonal expansion of peripheral B cells, single-cell PCR, phage display, yeast display, and mammalian cell display.  Our reliance on different strategies is shifting as we gain experience and refine methods to the efficient generation of human mAbs with superior pharmacokinetic and pharmacodynamic properties.

PMID:
20505349
PMCID:
PMC3180084
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center